Cytomegalic Inclusion DiseaseSymptoms, Doctors, Treatments, Advances & More
Cytomegalic Inclusion Disease Overview
Learn About Cytomegalic Inclusion Disease
MacGregor Infection Medicine And Travel Program
Emily Blumberg is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Blumberg is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, HIV/AIDS, Kidney Transplant, and Liver Transplant. Dr. Blumberg is currently accepting new patients.
Office
Mark Schleiss is an Infectious Disease provider in Minneapolis, Minnesota. Dr. Schleiss is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. His top areas of expertise are Congenital Cytomegalovirus, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Cryptococcosis, and Myringotomy.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.
Summary: This is a Phase 1 single-arm open-label study of letermovir in neonates with symptomatic congenital Cytomegalovirus (CMV) disease. There will be two groups enrolled. Group 1 will be comprised of 4 subjects. Following documentation study inclusion and signing of informed consent, Group 1 subjects will receive one dose of oral letermovir (Study Day 0), using the dose bands. A full pharmacokinetics (...
Summary: After allogeneic hematopoietic stem cell transplantation (allo-HSCT), recipients are immunocompromised and at increased risk of complications, including cytomegalovirus (CMV) infection. International clinical guidelines for the management of CMV infection post-allo-HSCT recommend three main strategies: minimizing infection risk, prevention, and preemptive therapy. However, traditional antiviral ag...


